bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 70.60
-1.25 (-1.74%)
Jul 31, 2026, 11:55 AM CET
bioMérieux Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 462.1 | 396.9 | 425.1 | 322.8 | 440.5 | 598.2 |
Depreciation & Amortization | 455.1 | 438.4 | 325.1 | 388.5 | 277 | 247.8 |
Stock-Based Compensation | 21.2 | 26.5 | 23.4 | 19.7 | 13 | 12.4 |
Other Adjustments | 102.8 | -2 | -55.3 | -82.3 | -99.5 | -11.7 |
Change in Receivables | -24.1 | -29 | -53.7 | -13.7 | -145.6 | 23.6 |
Changes in Inventories | 22 | -10.1 | -85.1 | -192.6 | -92.1 | -48.8 |
Changes in Accounts Payable | 22.6 | 3.4 | -0.6 | 3.4 | 9.9 | 24.2 |
Changes in Other Operating Activities | 9.1 | -35.6 | 88.4 | -0.4 | 71.9 | -21.8 |
Operating Cash Flow | 905.1 | 788.4 | 667.3 | 445.4 | 475.1 | 824.7 |
Operating Cash Flow Growth | 14.80% | 18.15% | 49.82% | -6.25% | -42.39% | 41.51% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -322.1 | -335.3 | -345.8 | -338.3 | -286.7 | -290.1 |
Sale of Property, Plant & Equipment | 7.2 | 10.4 | 9.4 | 6.4 | 17.4 | 20 |
Purchases of Investments | -4.6 | -5.2 | -13.4 | -156.9 | -53.8 | -3.7 |
Proceeds from Sale of Investments | -1.5 | -0.9 | -1.2 | 0 | 0 | 0.7 |
Cash Acquisitions | -27.1 | -130.5 | -8.8 | 0 | -205 | -33.5 |
Investing Cash Flow | -345.5 | -461.7 | -359.8 | -488.8 | -528.1 | -307.3 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 33.6 | 9.8 | 38.9 | 67.7 | 18.2 |
Long-Term Debt Repaid | -106.8 | -63.2 | -84.6 | -73.7 | -53.4 | -68.3 |
Net Long-Term Debt Issued (Repaid) | -106.8 | -29.6 | -74.8 | -34.8 | 14.3 | -50.1 |
Repurchase of Common Stock | -53.9 | -18.2 | -37.6 | 12.7 | -157.2 | -17.4 |
Net Common Stock Issued (Repurchased) | -53.9 | -18.2 | -37.6 | 12.7 | -157.2 | -17.4 |
Common Dividends Paid | -115.2 | -106.1 | -100.2 | -100.2 | -101.2 | -73.1 |
Other Financing Activities | 2.3 | -1.5 | 0 | 0 | 0 | 0 |
Financing Cash Flow | -277.9 | -155.4 | -212.6 | -122.3 | -244.2 | -140.6 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 16.4 | -48.4 | 13.9 | -29.7 | 38.7 | 39.2 |
Net Cash Flow | 281.4 | 171.3 | 94.8 | -165.7 | -297.2 | 376.8 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 583 | 453.1 | 321.5 | 107.1 | 188.4 | 534.6 |
Free Cash Flow Growth | 28.67% | 40.93% | 200.19% | -43.15% | -64.76% | 75.11% |
FCF Margin | 14.61% | 11.13% | 8.08% | 2.91% | 5.25% | 15.83% |
Free Cash Flow Per Share | 4.92 | 3.81 | 2.71 | 0.90 | 1.59 | 4.50 |
Levered Free Cash Flow | 542.5 | 428.7 | 339.4 | 183.4 | 446.7 | 462.3 |
Unlevered Free Cash Flow | 652.33 | 454.33 | 414 | 184.65 | 425.51 | 517.62 |